JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).

Moehler M. H., Ryu M., Lee K., Coskun H. S., Wong R., Ozguroglu M., ...More

Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 18 - 20 January 2018, vol.36, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 36
  • Doi Number: 10.1200/jco.2018.36.4_suppl.tps195
  • City: San-Francisco
  • Country: Costa Rica
  • Akdeniz University Affiliated: Yes